Breaking News Bar

Business News and Information

FDA committee sets stage for Epizyme's first product approval

After more than a decade of ups and downs in the drug development process, Cambridge biotech Epizyme is poised to start 2020 with good news after an FDA advisory committee voiced support for its cancer drug.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear